Clinical trial
COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI
NCT05790902 is registered in ClinicalTrials.gov with Armed Forces Institute of Urology, Rawalpindi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI
- Lead sponsor
- Armed Forces Institute of Urology, Rawalpindi
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- February 28, 2023
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
silodosin, tamsulosin, medical expulsive therapy, distal ureteric calculi